Sachdev Amit
EVP Chief Patient & Ext Af Off at VRTX
- Sold, on record
- $176M
- Dollars the filings state
- Form 4 sales
- 96
- Latest Feb 25, 2026
- Form 144 notices
- 2
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- VRTXVERTEX PHARMACEUTICALS INC / MAEVP Chief Patient & Ext Af Off
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale VRTXRoutineNov 15 2023
Sold 35 shares at $369.92 ($13k)
Sachdev Amit, EVP Chief Patient & Ext Af Off
10b5-1 planSold 0.1% of holdings ($21.8M position)58,814 shares leftFollows a Form 144Filing
- 2 Form 4 sale VRTXRoutineFeb 12 +89 days
Sold 3,222 shares at $420.24 ($1.4M)
Sachdev Amit, EVP Chief Patient & Ext Af Off
10b5-1 planSold 4.2% of holdings ($32.6M position)74,364 shares leftFiling
- 3 Form 4 sale VRTXRoutineFeb 20 +8 days
Sold 4,254 shares at $420.79 ($1.8M)
Sachdev Amit, EVP Chief Patient & Ext Af Off
10b5-1 planSold 6.2% of holdings ($28.7M position)63,989 shares left1.3x usual sizeFiling
- 4 Form 4 sale VRTXRoutineFeb 21 +1 day
Sold 3,191 shares at $421.77 ($1.3M)
Sachdev Amit, EVP Chief Patient & Ext Af Off
10b5-1 planSold 5% of holdings ($27M position)60,798 shares left0.9x usual sizeFiling
- 5 Form 4 sale VRTXRoutineFeb 26 +5 days
Sold 3,004 shares at $425.70 ($1.3M)
Sachdev Amit, EVP Chief Patient & Ext Af Off
10b5-1 planSold 5.2% of holdings ($24.8M position)55,325 shares left0.9x usual sizeFiling
- 6 Form 4 sale VRTXRoutineMay 15 +79 days
Sold 32 shares at $430.93 ($14k)
Sachdev Amit, EVP Chief Patient & Ext Af Off
10b5-1 planSold 0.1% of holdings ($23.9M position)55,325 shares left0x usual sizeFiling
- 7 Form 4 sale VRTXUnusualFeb 19 +645 days
Sold 58,613 shares at $468.83 ($27.5M)
Sachdev Amit, EVP Chief Patient & Ext Af Off
10b5-1 planSold 49.9% of holdings ($55.1M position)58,934 shares left18.9x usual sizeFiling
- 8 Form 4 sale VRTXRoutineFeb 25 +6 days
Sold 1,846 shares at $486.35 ($898k)
Sachdev Amit, EVP Chief Patient & Ext Af Off
10b5-1 planSold 3.2% of holdings ($27.9M position)55,570 shares left0.6x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (98)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Feb 25, 2026 | VRTX | EVP Chief Patient & Ext Af Off | Form 4 sale | 1,846 | $898k | 3.2% | Routine | SEC |
| Feb 19, 2026 | VRTX | EVP Chief Patient & Ext Af Off | Form 4 sale | 58,613 | $27.5M | 49.9% | Unusual | SEC |
| May 15, 2024 | VRTX | EVP Chief Patient & Ext Af Off | Form 4 sale | 32 | $14k | 0.1% | Routine | SEC |
| Feb 26, 2024 | VRTX | EVP Chief Patient & Ext Af Off | Form 4 sale | 3,004 | $1.3M | 5.2% | Routine | SEC |
| Feb 21, 2024 | VRTX | EVP Chief Patient & Ext Af Off | Form 4 sale | 3,191 | $1.3M | 5.0% | Routine | SEC |
| Feb 20, 2024 | VRTX | EVP Chief Patient & Ext Af Off | Form 4 sale | 4,254 | $1.8M | 6.2% | Routine | SEC |
| Feb 12, 2024 | VRTX | EVP Chief Patient & Ext Af Off | Form 4 sale | 3,222 | $1.4M | 4.2% | Routine | SEC |
| Nov 15, 2023 | VRTX | EVP Chief Patient & Ext Af Off | Form 4 sale | 35 | $13k | 0.1% | Routine | SEC |
| Nov 15, 2023 | VRTX | Officer | Form 144 notice | 35 | $13k | Notice | SEC | |
| Aug 10, 2023 | VRTX | EVP, Chief Patient Officer | Form 4 sale | 10,031 | $3.5M | 14.6% | Routine | SEC |
| Aug 10, 2023 | VRTX | Officer | Form 144 notice | 10,031 | $3.5M | Notice | SEC | |
| Nov 15, 2021 | VRTX | EVP, Chief Patient Officer | Form 4 sale | 51 | $10k | 0.2% | Plan not stated | SEC |
| May 17, 2021 | VRTX | EVP, Chief Patient Officer | Form 4 sale | 45 | $10k | 0.1% | Plan not stated | SEC |
| Apr 27, 2021 | VRTX | EVP, Chief Patient Officer | Form 4 sale | 3,884 | $839k | 8.8% | Plan not stated | SEC |
| Feb 25, 2021 | VRTX | EVP, Chief Patient Officer | Form 4 sale | 3,586 | $765k | 8.2% | Plan not stated | SEC |
| Feb 18, 2021 | VRTX | EVP, Chief Patient Officer | Form 4 sale | 9,264 | $2M | 16.6% | Plan not stated | SEC |
| Feb 11, 2021 | VRTX | EVP, Chief Patient Officer | Form 4 sale | 4,460 | $939k | 6.6% | Plan not stated | SEC |
| Nov 16, 2020 | VRTX | EVP, Chief Patient Officer | Form 4 sale | 42 | $9k | 0.1% | Plan not stated | SEC |
| Aug 3, 2020 | VRTX | EVP, Chief Patient Officer | Form 4 sale | 1,941 | $540k | 5.2% | Plan not stated | SEC |
| May 15, 2020 | VRTX | EVP, Chief Patient Officer | Form 4 sale | 58 | $16k | 0.2% | Plan not stated | SEC |
| May 11, 2020 | VRTX | EVP, Chief Patient Officer | Form 4 sale | 10,665 | $3M | 23.3% | Plan not stated | SEC |
| May 6, 2020 | VRTX | EVP, Chief Patient Officer | Form 4 sale | 669 | $184k | 1.9% | Plan not stated | SEC |
| May 5, 2020 | VRTX | EVP, Chief Patient Officer | Form 4 sale | 57,108 | $15.1M | 61.9% | Unusual | SEC |
| Feb 25, 2020 | VRTX | EVP, Chief Patient Officer | Form 4 sale | 3,376 | $788k | 9.3% | Plan not stated | SEC |
| Feb 18, 2020 | VRTX | EVP, Chief Patient Officer | Form 4 sale | 3,489 | $850k | 8.1% | Plan not stated | SEC |
| Feb 11, 2020 | VRTX | EVP, Chief Patient Officer | Form 4 sale | 13,070 | $3.2M | 22.1% | Unusual | SEC |
| Feb 3, 2020 | VRTX | EVP, Chief Patient Officer | Form 4 sale | 4,097 | $947k | 10.2% | Plan not stated | SEC |
| Jan 16, 2020 | VRTX | EVP, Chief Patient Officer | Form 4 sale | 5,000 | $1.2M | 12.1% | Plan not stated | SEC |
| Jan 8, 2020 | VRTX | EVP, Chief Patient Officer | Form 4 sale | 5,000 | $1.1M | 12.1% | Plan not stated | SEC |
| Dec 9, 2019 | VRTX | EVP, Chief Patient Officer | Form 4 sale | 5,000 | $1.1M | 13.0% | Plan not stated | SEC |
| Nov 25, 2019 | VRTX | EVP, Chief Patient Officer | Form 4 sale | 5,000 | $1.1M | 13.0% | Plan not stated | SEC |
| Nov 19, 2019 | VRTX | EVP, Chief Patient Officer | Form 4 sale | 5,000 | $1.1M | 13.0% | Plan not stated | SEC |
| Nov 15, 2019 | VRTX | EVP, Chief Patient Officer | Form 4 sale | 57 | $12k | 0.2% | Plan not stated | SEC |
| Nov 4, 2019 | VRTX | EVP, Chief Patient Officer | Form 4 sale | 4,097 | $821k | 10.9% | Plan not stated | SEC |
| Oct 25, 2019 | VRTX | EVP, Chief Patient Officer | Form 4 sale | 4,311 | $841k | 11.4% | Plan not stated | SEC |
| Oct 22, 2019 | VRTX | EVP, Chief Patient Officer | Form 4 sale | 3,883 | $739k | 10.4% | Plan not stated | SEC |
| May 15, 2019 | VRTX | EVP, CRO | Form 4 sale | 61 | $10k | 0.2% | Plan not stated | SEC |
| Feb 11, 2019 | VRTX | EVP, CRO | Form 4 sale | 35,095 | $6.3M | 46.6% | Unusual | SEC |
| Feb 4, 2019 | VRTX | EVP, CRO | Form 4 sale | 12,722 | $2.4M | 25.1% | Unusual | SEC |
| Nov 15, 2018 | VRTX | EVP, CRO | Form 4 sale | 61 | $10k | 0.1% | Plan not stated | SEC |
| Nov 5, 2018 | VRTX | EVP, CRO | Form 4 sale | 4,096 | $710k | 8.1% | Plan not stated | SEC |
| Aug 3, 2018 | VRTX | EVP, CRO | Form 4 sale | 4,097 | $721k | 8.1% | Plan not stated | SEC |
| Jul 16, 2018 | VRTX | EVP, CRO | Form 4 sale | 13,750 | $2.5M | 22.8% | Plan not stated | SEC |
| Jun 29, 2018 | VRTX | EVP, CRO | Form 4 sale | 4,096 | $687k | 8.1% | Plan not stated | SEC |
| May 15, 2018 | VRTX | EVP, CRO | Form 4 sale | 83 | $13k | 0.2% | Plan not stated | SEC |
| Mar 9, 2018 | VRTX | EVP, CRO | Form 4 sale | 13,750 | $2.4M | 22.8% | Plan not stated | SEC |
| Feb 26, 2018 | VRTX | EVP, CRO | Form 4 sale | 2,155 | $366k | 4.4% | Plan not stated | SEC |
| Feb 12, 2018 | VRTX | EVP, CRO | Form 4 sale | 17,796 | $2.7M | 27.6% | Unusual | SEC |
| Feb 5, 2018 | VRTX | EVP, CRO | Form 4 sale | 4,520 | $737k | 10.3% | Plan not stated | SEC |
| Jan 29, 2018 | VRTX | EVP, CRO | Form 4 sale | 15,085 | $2.6M | 27.8% | Unusual | SEC |
| Jan 23, 2018 | VRTX | EVP, CRO | Form 4 sale | 5,824 | $961k | 12.9% | Plan not stated | SEC |
| Jan 22, 2018 | VRTX | EVP, CRO | Form 4 sale | 46,172 | $7.3M | 54.1% | Unusual | SEC |
| Nov 15, 2017 | VRTX | EVP, CRO | Form 4 sale | 83 | $12k | 0.2% | Plan not stated | SEC |
| Oct 31, 2017 | VRTX | EVP, CRO | Form 4 sale | 40,000 | $5.8M | 44.1% | Unusual | SEC |
| Jul 21, 2017 | VRTX | EVP, CRO | Form 4 sale | 28,625 | $4.6M | 24.0% | Unusual | SEC |
| Jun 1, 2017 | VRTX | EVP, CRO | Form 4 sale | 30,500 | $3.8M | 23.5% | Unusual | SEC |
| May 15, 2017 | VRTX | EVP, CRO | Form 4 sale | 116 | $13k | 0.1% | Plan not stated | SEC |
| Mar 29, 2017 | VRTX | EVP, CRO | Form 4 sale | 80,500 | $8.7M | 44.8% | Unusual | SEC |
| Feb 13, 2017 | VRTX | EVP, CRO | Form 4 sale | 7,684 | $674k | 7.2% | Plan not stated | SEC |
| Nov 15, 2016 | VRTX | EVP, Policy, Access & Value | Form 4 sale | 116 | $11k | 0.1% | Plan not stated | SEC |
| May 16, 2016 | VRTX | EVP, Policy, Access & Value | Form 4 sale | 117 | $10k | 0.1% | Plan not stated | SEC |
| Feb 3, 2016 | VRTX | EVP, Policy, Access & Value | Form 4 sale | 10,166 | $923k | 10.6% | Plan not stated | SEC |
| Nov 16, 2015 | VRTX | EVP, Policy, Access & Value | Form 4 sale | 85 | $10k | 0.1% | Plan not stated | SEC |
| Oct 30, 2015 | VRTX | EVP, Policy, Access & Value | Form 4 sale | 5,938 | $745k | 7.0% | Plan not stated | SEC |
| May 15, 2015 | VRTX | EVP, Policy, Access & Value | Form 4 sale | 131 | $16k | 0.2% | Plan not stated | SEC |
| Mar 23, 2015 | VRTX | EVP, Policy, Access & Value | Form 4 sale | 17,083 | $2.3M | 16.8% | Plan not stated | SEC |
| Mar 18, 2015 | VRTX | EVP, Policy, Access & Value | Form 4 sale | 12,000 | $1.6M | 11.8% | Plan not stated | SEC |
| Feb 18, 2015 | VRTX | EVP, Policy, Access & Value | Form 4 sale | 5,937 | $670k | 6.2% | Plan not stated | SEC |
| Jan 9, 2015 | VRTX | EVP, Policy, Access & Value | Form 4 sale | 12,000 | $1.5M | 13.2% | Plan not stated | SEC |
| Nov 28, 2014 | VRTX | EVP, Policy, Access & Value | Form 4 sale | 12,000 | $1.4M | 13.2% | Plan not stated | SEC |
| Nov 17, 2014 | VRTX | EVP, Policy, Access & Value | Form 4 sale | 134 | $15k | 0.2% | Plan not stated | SEC |
| Oct 28, 2014 | VRTX | EVP, Policy, Access & Value | Form 4 sale | 12,000 | $1.4M | 23.7% | Plan not stated | SEC |
| Sep 30, 2014 | VRTX | SVP, Global Gov. Strategy | Form 4 sale | 86,000 | $9.7M | 69.0% | Unusual | SEC |
| Jun 24, 2014 | VRTX | SVP, Global Gov. Strategy | Form 4 sale | 42,250 | $4.1M | 52.2% | Unusual | SEC |
| Dec 12, 2013 | VRTX | SVP, Global Gov. Strategy | Form 4 sale | 2,542 | $166k | 8.7% | Plan not stated | SEC |
| Jul 19, 2013 | VRTX | SVP, Global Gov. Strategy | Form 4 sale | 22,250 | $2M | 43.4% | Unusual | SEC |
| Jul 12, 2013 | VRTX | SVP, Global Gov. Strategy | Form 4 sale | 44,500 | $3.8M | 60.6% | Unusual | SEC |
| Jul 5, 2013 | VRTX | SVP, Global Gov. Strategy | Form 4 sale | 61,907 | $5M | 68.1% | Unusual | SEC |
| Nov 16, 2012 | VRTX | SVP, Corp Affairs & Pub Policy | Form 4 sale | 2,287 | $94k | 10.8% | Plan not stated | SEC |
| Sep 21, 2012 | VRTX | SVP, Corp Affairs & Pub Policy | Form 4 sale | 9,531 | $562k | 31.1% | Unusual | SEC |
| Sep 14, 2012 | VRTX | SVP, Corp Affairs & Pub Policy | Form 4 sale | 47,812 | $2.7M | 69.4% | Unusual | SEC |
| May 7, 2012 | VRTX | SVP, Corp Affairs & Pub Policy | Form 4 sale | 58,750 | $3.1M | 65.4% | Unusual | SEC |
| Mar 30, 2012 | VRTX | SVP, Corp Affairs & Pub Policy | Form 4 sale | 26,562 | $1.1M | 44.1% | Unusual | SEC |
| Feb 8, 2012 | VRTX | SVP, Corp Affairs & Pub Policy | Form 4 sale | 4,066 | $150k | 9.0% | Plan not stated | SEC |
| Jan 19, 2012 | VRTX | SVP, Corp Affairs & Pub Policy | Form 4 sale | 4,066 | $150k | 10.4% | Plan not stated | SEC |
| Jul 25, 2011 | VRTX | SVP, Corp Affairs & Pub Policy | Form 4 sale | 1,500 | $75k | 3.7% | Plan not stated | SEC |
| Mar 3, 2011 | VRTX | SVP, Corp Affairs & Pub Policy | Form 4 sale | 9,531 | $472k | 19.2% | Plan not stated | SEC |
| Feb 28, 2011 | VRTX | SVP, Corp Affairs & Pub Policy | Form 4 sale | 15,887 | $727k | 28.3% | Unusual | SEC |
| Feb 23, 2011 | VRTX | SVP, Corp Affairs & Pub Policy | Form 4 sale | 23,828 | $1M | 35.1% | Unusual | SEC |
| Jan 21, 2011 | VRTX | SVP, Corp Affairs & Pub Policy | Form 4 sale | 2,128 | $85k | 5.9% | Plan not stated | SEC |
| Jan 18, 2011 | VRTX | SVP, Corp Affairs & Pub Policy | Form 4 sale | 15,664 | $625k | 30.3% | Unusual | SEC |
| Jan 11, 2011 | VRTX | SVP, Corp Affairs & Pub Policy | Form 4 sale | 451 | $17k | 1.1% | Plan not stated | SEC |
| Oct 28, 2010 | VRTX | SVP, Corp Affairs & Pub Policy | Form 4 sale | 4,750 | $183k | 10.6% | Unusual | SEC |
| Oct 26, 2010 | VRTX | SVP, Public Policy,Gov Affairs | Form 4 sale | 4,534 | $170k | 9.2% | Unusual | SEC |
| Oct 18, 2010 | VRTX | SVP, Public Policy,Gov Affairs | Form 4 sale | 1,000 | $37k | 2.0% | Plan not stated | SEC |
| Oct 15, 2010 | VRTX | SVP, Public Policy,Gov Affairs | Form 4 sale | 1,000 | $35k | 1.9% | Plan not stated | SEC |
| May 18, 2009 | VRTX | SVP, Corp Affairs & Pub Policy | Form 4 sale | 783 | $22k | 1.9% | Plan not stated | SEC |
| Nov 18, 2008 | VRTX | SVP, Public Policy,Gov Affairs | Form 4 sale | 791 | $21k | 2.7% | Plan not stated | SEC |